Radical Resection of Single-hole Inflatable Mediastinal Mirror Synchronization With Laparoscopic Esophageal Carcinoma
NCT03657914 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 155
Last updated 2018-09-05
Summary
This study is evaluating the feasibility and safety of radical resection of single-hole inflatable mediastinal mirror synchronization with laparoscopic esophageal carcinoma, as well as the clinical value of the radical resection of single-hole inflatable mediastinal mirror synchronization with laparoscopic esophageal carcinoma as a new minimally invasive operation for esophageal carcinoma.
Conditions
- Esophagus Cancer
Interventions
- PROCEDURE
-
Single-hole inflatable mediastinal mirror
The radical resection of single-hole inflatable mediastinal mirror synchronization with laparoscopic esophageal carcinoma is new minimally invasive operation for esophageal carcinoma. All enrolled subjects will receive this operation for their ESCC.
Sponsors & Collaborators
-
Qingdong Cao
lead OTHER
Principal Investigators
-
Liu Shaoxuan, master · Office of clinical research center
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-12
- Primary Completion
- 2019-03-31
- Completion
- 2019-03-31
Countries
- China
Study Locations
More Related Trials
-
A Observational Study to Compare Effectiveness and Safety of the Surgeries in Patients With Esophageal Cancer
NCT03428074 ·Status: COMPLETED
-
Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus Cancer
NCT03120572 ·Status: COMPLETED
-
Cytosponge in Surveillance After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma
NCT06429865 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma
NCT04275986 ·Status: UNKNOWN ·Phase: PHASE2
-
Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal Cancer
NCT05349045 ·Status: UNKNOWN
-
Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02)
NCT07317609 ·Status: RECRUITING ·Phase: PHASE1
-
Minimally Invasive Intrathoracic Esophagogastric Side to Side Anastomosis vs. End to Side Anastomosis
NCT05812495 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Trial of Esophagectomy for Esophageal Carcinoma
NCT06691503 ·Status: COMPLETED ·Phase: PHASE2
-
Lifting of Gastric Tube Through Trans-substernal Versus Trans-esophageal Bed Path in MIE
NCT02309619 ·Status: UNKNOWN ·Phase: NA
-
Coldplay Cryoablation of Dysplastic Squamous Tissue in Patients With Esophageal Squamous Cell Dysplasia
NCT02605759 ·Status: COMPLETED ·Phase: NA
-
Multicenter Cohort Study of ESD and Chemo-radiotherapy for High-risk Early-stage Esophageal Cancer
NCT06385717 ·Status: RECRUITING
-
A Transoral Retropterygoid Approach to Resect Recurrent Nasopharyngeal Carcinoma
NCT05432219 ·Status: UNKNOWN ·Phase: NA
-
Endoscopic Submucosal Dissection Versus Esophagectomy for Early Esophageal Carcinoma
NCT06060106 ·Status: COMPLETED
-
Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients
NCT05596890 ·Status: UNKNOWN ·Phase: PHASE2
-
Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma
NCT05833594 ·Status: RECRUITING
-
NeoAdjuvant Therapy With Immunoreagent (SHR-1316) for Resectable Oesophageal Squamous Cell carciNoma
NCT04215471 ·Status: UNKNOWN ·Phase: PHASE2
-
Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy
NCT06889402 ·Status: NOT_YET_RECRUITING
-
A Clinical Study of Non-curative Resection Plus Radiotherapy After Endoscopic ESD for Superficial Esophageal Squamous Cell Carcinoma
NCT06160557 ·Status: ENROLLING_BY_INVITATION
-
An Observational Study to Evaluate Lymph Metastases and Prognoses of the Patients With Esophageal Cancer
NCT03415815 ·Status: UNKNOWN
-
Influence of Different Light Dose on the Adverse Effect of Swallowing for Esophageal Carcinoma
NCT05174117 ·Status: UNKNOWN ·Phase: NA
-
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT05740995 ·Status: RECRUITING
-
Precisely Estimation of the Prognostic Value of Lymph Node in ESCC
NCT04764240 ·Status: COMPLETED
-
Evaluation of Neoadjuvant Therapy Efficacy and Postoperative Pathological Indicators in Esophageal Cancer Using CT and Multimodal MRI
NCT06833775 ·Status: NOT_YET_RECRUITING
-
Early Detection of Esophageal Cancer
NCT00341523 ·Status: TERMINATED
-
C2 Esophageal Squamous Epithelium Dysplasia
NCT05349240 ·Status: RECRUITING ·Phase: NA